Challenges around data are mostly around data itself, particularly if it is not timely, says Lee A. Norman, MD, MHS, MBA, the senior medical director for Optum Care Kansas City.
The data used in clinical decision-making needs to be as real time as possible, said Lee A. Norman, MD, MHS, MBA, who appeared at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on population health in Kansas City, Missouri. He served as the secretary of the Kansas Department of Health and Environment from 2019 to 2021 under Governor Laura Kelly. Norman, who also served in the US Air Force and later as a colonel in the Kansas Army National Guard, is currently senior medical director for Optum Care Kansas City.
Transcript
What are some of the challenges to implementing data in health care practices improve patient care?
The challenges are mostly around data itself, which is, do we have the quality of data and is it timely? I can remember back in the olden days, let's say in the mid-80s, where we signed up to take care of patients and HMO [health management organization] plans, and we didn't have any data as the month would go along. And then all of a sudden, at the end of the year, we'd find out how we did, both in terms of clinical data and in terms of financial performance. That's not adequate. Those plans went bye-bye.
What is really necessary now is data that's almost as real time as possible and [that can] help us to understand where are we strong? Where are we weak? How does this patient fare in this value-based world compared to the fee-for-service world? There shouldn't be a whole vast difference between those worlds as it relates to patient outcomes. But it's very critical, and it always has been, but we're getting better at it, to have data at our fingertips to make good clinical decision-making.
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen